Introduction: Controversies in Hypertension
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Antihypertensive therapy: safety and efficacy of drugs and publications;Frohlich;Journal of hypertension,1996
2. Antihypertensive therapy: safety and efficacy of drugs and publications;Frohlich;Hypertension,1996
3. Cardiovascular protection using beta-blockers: a critical review of the evidence;Bangalore;Journal of the American College of Cardiology,2007
4. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus;Bangalore;The American journal of cardiology,2007
5. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);James;JAMA,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Levobunolol-imprinted polymer: a theoretical study;Journal of Molecular Modeling;2023-10-20
2. Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort;Heart;2018-04-24
3. Blood pressure measurements for treating hypertension: which method counts the most?;Heart;2018-03-19
4. Four Years as Editor-in-Chief;Progress in Cardiovascular Diseases;2018-01
5. More SPRINT controversy;Journal of Internal Medicine;2017-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3